Janus Henderson Investors US’s ResMed RMD Stock Holding History
Bought
Maintained
Sold
Other funds holding RMD
CBOA
Janus Henderson Investors US's RMD Position: Q1 2017 in Review
Janus Henderson Investors US reduced its ResMed (RMD) stake by 35% in Q1 2017, selling an estimated $17.6M and leaving 472,214 shares worth $34M. The position accounts for 0.03% of the portfolio, ranked #517.
Janus Henderson Investors US first reported a position in RMD in Q2 2013 and has held it in 16 quarters since. The position peaked at $51.6M in Q2 2013. 374 funds tracked by Wall St. Rank hold RMD as of Q1 2017.
- Janus Henderson Investors US held 472,214 shares of ResMed worth $34M as of Q1 2017.
- Janus Henderson Investors US sold 255,300 ResMed shares in Q1 2017, an estimated $17.6M.
- ResMed made up 0.03% of Janus Henderson Investors US's portfolio in Q1 2017, its #517 holding.
- Janus Henderson Investors US first reported a position in ResMed in Q2 2013 and has held it in 16 quarters since.
- Janus Henderson Investors US's ResMed position peaked at $51.6M in Q2 2013.
- 374 funds tracked by Wall St. Rank held ResMed as of Q1 2017.
Based on Janus Henderson Investors US's 13F filing for Q1 2017, filed 16 May 2017.